Fundraising FoxGoodwin Biotechnology
Plantation, US · Delaware corporation · 1 known investors
Find your way into Goodwin Biotechnology
Sign up to see every warm intro you have to Goodwin Biotechnology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Goodwin Biotechnology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KP
Karl PintoExecutive
SV
Steven VorgityExecutive
SS
SooYoung S. LeeChief Operating Officer and Secretary
CM
Cesar MenezesNamed on SEC filing
ME
Maria Emila MenezesNamed on SEC filing
JL
Jerry LiaoNamed on SEC filing
SK
Sunil K. AgarwalFinancial Controller and Treasurer
Board
NP
Nikhil PuriBoard director
BP
Brandon PriceBoard director
KP
Kent PayneBoard director
DM
Divya MenezesBoard director
Investors · 1
Signet Healthcare PartnersreportedNew York · $10M – $50M
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$30.7M disclosed across 4 rounds · 2019–2025
▶$2MraisedJan 2026 · 2 investors · Other Health CareRule 506(b)
▶$2MraisedJan 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Karl PintoExecutive Officer, Director
- Nikhil PuriDirector
- Brandon PriceDirector
- Kent PayneDirector
- Divya MenezesDirector
- Steven VorgityExecutive Officer
- Offering amount
- $4M
- Amount sold
- $2M
- Minimum investment
- $1M
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b, 4a5
▶$3MraisedNov 2024 · 1 investors · Other Health CareRule 506(b)
▶$3MraisedNov 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Karl PintoExecutive Officer, Director
- Nikhil PuriDirector
- Kent PayneDirector
- Divya MenezesDirector
- Steven VorgityExecutive Officer
- Brandon PriceDirector
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $3M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b, 4a5
▶$5MraisedOct 2023 · 3 investors · Other Health CareRule 506(b)
▶$5MraisedOct 2023 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kent PayneDirector
- Karl PintoDirector
- Darrin SchellinExecutive Officer, Director
- Divya MenezesDirector
- Nikhil PuriDirector
- Brandon PriceDirector
- Steven VorgityExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $522.5K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b, 4a5
▶$20.7MraisedApr 2019 · 5 investors · BiotechnologyRule 506(b)
▶$20.7MraisedApr 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karl PintoExecutive Officer, Director
- SooYoung S. LeeExecutive Officer
- Sunil K. AgarwalExecutive Officer
- Cesar MenezesDirector
- Divya MenezesDirector
- Maria Emila MenezesDirector
- Nikhil PuriDirector
- Jerry LiaoDirector
- Offering amount
- $20.7M
- Amount sold
- $20.7M
- Sales commissions
- $600K
- Placement agents
- Cornelius P. McCarthy III
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Goodwin Biotechnology's investors?
- Goodwin Biotechnology's investors include Signet Healthcare Partners.
- How much funding has Goodwin Biotechnology raised?
- Goodwin Biotechnology has disclosed $30.7M raised across 4 rounds.
- Where is Goodwin Biotechnology headquartered?
- Goodwin Biotechnology is headquartered in Plantation, US.